biOasis Technologies Inc. | Key People and Executives
Mark Day
President, Chief Executive Officer & Director
David M. Wurzer
Independent Director
John E. Curran
Independent Director
Nancy E. Stagliano
Independent Director
Mark Day
President, Chief Executive Officer & Director
Christopher P. Lowe
Chief Financial Officer & Secretary
Caroline Hill
Senior VP & Head-Research & Development Operations
Mei Mei Tian
Vice President & Head-External Research
Doug Williams
Chief Business Officer & Executive Vice President
Catherine London
EVP, Head-Communications & Investor Relations
David M. Wurzer
Independent Director
John E. Curran
Independent Director
Nancy E. Stagliano
Independent Director
| Address |
14 Water Street
Guilford Connecticut 06437
United States
|
|
Employees
|
- |
| Website |
http://www.bioasis.ca |
| Updated |
07/08/2019 |
| biOasis Technologies, Inc. is a biopharmaceutical company focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include Transcend program as its proprietary carrier, p97, and components thereof, to deliver therapeutics and imaging agents across the blood brain barrier. The company was founded by Rob Hutchison on May 3, 2007 and is headquartered in Vancouver, Canada. |
